30 East 33rd Street
New York, NY 10016
800.622.9010
www.kidney.org
ANNUAL REPORT
© 2007 National Kidney Foundation, Inc. All rights reserved.
03-25-2006
2006
TABLE OF CONTENTS
A MESSAGE FROM OUR LEADERS
2
UP FRONT
5
PUBLIC EDUCATION
FOCUS ON: CAROLYN PRICE
8
PATIENT SERVICES
FOCUS ON: MARY WENDT
12
ORGAN AND TISSUE DONATION
FOCUS ON: EMILY BIONDI
16
PROFESSIONAL EDUCATION
FOCUS ON: DR. LESLIE SPRY
20
ADVOCACY
FOCUS ON: JIM MCDERMOTT
24
RESEARCH
FOCUS ON: DR. ROBYN CUNARD
28
FUNDRAISING
FOCUS ON: ROY MALKIN
32
CORPORATE PARTNERS
36
OUR SUPPORTERS
37
LEADERSHIP & AFFILIATES
41
REPORT OF INDEPENDENT AUDITORS
44
NOTES
49
COMBINED FINANCIAL STATEMENTS
52
EDITORIAL DIRECTOR: Ellie Schlam
EDITOR: Jamie Biegeleisen
GRAPHIC DESIGN: Silvia Avramov
COVER PHOTOGRAPHS: Erica Berger, Eric Miller, Allison Michael Orenstein
CONTRIBUTING WRITERS: Christina Cheakalos, Geraldine Connors,
Patricia O’Connor, Bryan Van Steenbergen, Kerry Willis
Photo: Acey Harper
FROM OUR LEADERS
Every day, the National Kidney Foundation (NKF) is achieving life-saving results in cities and
communities across the U.S. One day, it’s the mom who found out at our free screening
that she had early signs of kidney disease, and who is now taking steps to prevent further
complications. The next day it’s a kidney transplant recipient who won a gold medal at the
Foundation’s Olympic-style U.S. Transplant Games. The next week, it’s the longtime dialysis
patient who has newfound courage to speak up and visit his local congressman to advocate for legislation that increases his Medicare benefits, thanks to the Foundation’s patient
empowerment initiative.
These are the kind of results that truly define the NKF. Our visual identity was solidified
with consistent use of our new logo, and we moved into the next phase of our rebranding initiative. This included taking stock of the truths about the NKF brand, its benefits and
personality, and articulating the brand vision that will guide us today and into the future.
This process culminated with the development of a brand positioning that signifies what we
stand for, and focused all of our efforts. The new positioning statement is life-saving results
today, and we are delivering those results in a way that differentiates NKF from its competition—with hope, empowerment and information.
The positioning process pushed us to take a long, hard look at who we are and where we are
headed. As a result, we embarked upon a major strategic planning initiative. We identified our
key goals and set measurable objectives and strategies to help us reach them. These goals,
which support our new positioning, include empowering patients and families, and improving
treatment for those at risk and those who are already living with kidney disease.
Through signature Foundation programs such as the Olympic-style U.S. Transplant Games, our
ongoing “People Like Us” patient empowerment initiative, the Kidney Early Evaluation Program
(KEEP)™ and Kidney Disease Outcomes Quality Initiative (KDOQI)™ clinical practice guideline
development process, the NKF is delivering life-saving results to our key constituents—those at
risk, patients, organ donors, the medical community and our supporters. As you read through
this report, you’ll see exactly how the National Kidney Foundation is combining tangible results
with a caring, human touch that is inspiring positive action on so many fronts.
John Davis, CEO
David G. Warnock, MD
“...THE NKF IS DELIVERING LIFE-SAVING RESULTS TO OUR KEY
CONSTITUENTS—THOSE AT RISK, PATIENTS, ORGAN DONORS,
THE MEDICAL COMMUNITY AND OUR SUPPORTERS.”
Chuck Fruit, Chairman
02
03
UP FRON
REACHING OUT...
5,000,000
PAGE VIEWS ON
OUR WEB SITE, WWW.KIDNEY.ORG
38,000 VOLUNTEERS NATIONWIDE
$2,400,000 SPENT ON RESEARCH
ON CHRONIC KIDNEY DISEASE
22,000 PEOPLE RECEIVED FREE
SCREENINGS FOR KIDNEY DISEASE
47,500 CONSTITUENT COUNCIL MEMBERS
265,529,182 TOTAL MEDIA IMPRESSIONS
342,000 READERS OF QUARTERLY
FAMILY FOCUS NEWSPAPER FOR
DIALYSIS PATIENTS, THEIR
FAMILY MEMBERS AND HEALTH
CARE PROFESSIONALS
04
05
UP FRONT
BURL OSBORNE
Burl Osborne approaches
membership on the
National Kidney Foundation
Board of Directors as he
does most everything else
in life: with a journalist’s
scrutinizing eye. In the five years since he retired
as CEO of The Dallas Morning News, Osborne has
accepted posts on several boards, which currently
include that of chairman of The Associated Press.
His standards are high, so he chooses his commitments very carefully. To the 69-year-old Osborne, the
NKF was a natural choice. Not only does he believe
the organization does an admirable job, Osborne also
happens to be a two-time kidney transplant recipient. His mother donated the first in 1966; the second
came from his brother in 1994. “On Halloween, to
be exact,” he recalls, laughing. Osborne says he is
“particularly pleased” with the NKF’s KEEP education
and screening program. “I’m most drawn to patientcentered activities,” says Osborne, who lives in
Dallas. “The most important thing we must do is act
responsibly and make sure that what we do is credible, that we are an advocate for patients. Whether
they need treatment or transplants, or both, our role
is to make sure they get whatever it is they need
to live quality lives.”
Photo: Eric Miller
2006 U.S. TRANSPLANT GAMES
The 2006 U. S. Transplant Games, presented by the National Kidney Foundation, was an Olympicstyle event for recipients of life-saving organ transplants. The Games represented the largest-ever
gathering of transplant recipients, donor families, living donors and transplant professionals.
While showcasing the success of transplantation, the event called attention to the great need for
organ donors and honored those who made it all possible—the living donors and the families of
organ and tissue donors.
Photos: Erica Berger
DONOR MOM MEETS RECIPIENT OF DAUGHTER’S KIDNEY
AT U.S. TRANSPLANT GAMES
Debbie Waddell was a 47-year-old mother and grandmother when she suffered multiple brain aneurisms.
“Donating her organs, which is what Debbie wanted,
changed my life,” says Meyers, who works at a hospital coffee bar. “There isn’t anything I won’t do to promote organ donation. I’ll shout it from rooftops. I miss
my daughter every single day, but knowing that her
organs are helping others’ live feels right.”
YOUR DONATION DOLLAR
8.8%
MANAGEMENT
& GENERAL
9.0%
FUNDRAISING
7.3%
RESEARCH
Photo left to right: Tim Bell, donor’s oldest son; Carrie Conley, kidney
recipient; Darrel Conley, Carrie’s husband; Linda Meyers, donor’s mother.
17.0%
PUBLIC HEALTH
EDUCATION
14.0%
COMMUNITY
SERVICE
24.4%
19.5%
PROFESSIONAL
EDUCATION
PATIENT SERVICES
06
07
When Carrie Conley met Linda Meyers for the first
time in a Louisville hotel lobby, she did something
that brought tears to both their eyes. “I placed Linda’s
hand where her daughter’s kidney was located,” says
Conley, a retired teacher who received a life-saving
kidney transplant on Mother’s Day 2004. The two
women had communicated through letters and a
phone call, but hadn’t set eyes on each other until both
came to Kentucky for the National Kidney Foundation’s
2006 U.S. Transplant Games. “I loved her already,”
says Meyers, 69, of Springfield, Missouri. “Through
her, Debbie, my firstborn and only daughter, lives on.”
Conley, who lost her own mother and other relatives to
polycystic kidney disease, says she has never felt better. She proved it at the Transplant Games by winning a
whopping four medals for everything from swimming
to golfing. Throughout every competition, Meyers was
rooting her on. “I just kept saying, ‘I’m so proud of
you!’ And I was. That girl sure can swim!” Since the
transplant, Conley has the strength to swim 20 laps
and play 18 holes of golf on a regular basis. “I am so
grateful,” she says. “Every Sunday, I pray for Linda and
her family and light a candle for Debbie. What Linda did
is awesome. I feel very lucky to know her and to honor
Debbie by being the healthiest person I can.”
EMPOWERING CONSUMERS WITH
KNOWLEDGE ABOUT WHO IS AT RISK AND
WHEN TO GET KIDNEY FUNCTION TESTED
WAS THE FOCUS OF THIS YEAR’S PUBLIC
PUBLIC EDUCATION
EDUCATION INITIATIVES. THROUGH
FREE KIDNEY SCREENINGS, PUBLIC
SERVICE CAMPAIGNS AND COMMUNITY
OUTREACH, OUR LIFE-SAVING MESSAGE
OF EARLY DETECTION REACHED MILLIONS.
08
09
Photo: Erica Berger
Photo: Erica Berger
EARLY DETECTION SAVES LIVES
The Foundation’s Kidney Early Evaluation Program (KEEP) is finding kidney disease at the
earliest stage when prevention of kidney failure is still possible. This year, KEEP offered
free screenings to 22,000 people in communities across the U.S. Although ninety percent
of KEEP participants had visited their doctors in the 12 months prior to the screening, most
were not aware they could be at risk for chronic kidney disease (CKD). In many cases,
doctors were treating high blood pressure and diabetes alone, but not as risk factors for
CKD, so the participants had not had their kidney function tested at regular checkups.
After the screenings, 60% reported consulting with their doctors about the results and
NKF’s treatment recommendations. KEEP is supported by Abbott, Amgen, Novartis
Pharmaceuticals, Ortho Biotech Products, L.P., Siemens Medical Solutions Diagnostics,
Lifescan, Inc, OceanSpray Cranberries, Inc. and Suplena®.
This year, the NKF helped spark a national conversation on the power of early detection
by joining forces with Foundation spokesperson George Lopez in a special episode of his
popular ABC TV sitcom, “The George Lopez Show.” “The Kidney Stays in the Picture”
episode was followed by a post-show informational announcement. As a result, the National
Kidney Foundation received more than 3,500 hits to our Web site and more than 500 calls to
our national hotline. NKF distributed hundreds of “Are You at Risk?” brochures and nearly 700
people downloaded the Spanish version of that publication from NKF’s Web site.
FIRST-EVER WORLD KIDNEY DAY
CA R O LY N P R I C E
In March, the Foundation took the lead on promotion for the first-ever World Kidney
Day, a newly-established annual health observance designed to raise awareness about
risk factors and early detection. Through print public service announcements in USA
Today, national radio interviews, and news stories in local papers and TV broadcasts
around the country, NKF encouraged Americans to take one positive action that day—to
learn their family’s health history and get checked out if they learn they are at risk.
Photo: Rob Tannenbaum
“They see how good I look, how healthy I am. That’s so important to see a living,
breathing example of a transplant recipient, particularly an African-American, like them.”
“Advocate” is far too passive a word for Carolyn Price.
The Jackson, Mississippi native is a force of nature who
stormed (politely, of course!) Capitol Hill in April, along
with other “People Like Us” patient advocates. Her
mission was to educate lawmakers about the crucial
need to allocate money for all aspects of organ donation,
ranging from research to financial reimbursement for
living donors. Price didn’t stop after successfully enlisting
her congressman, Rep. Bennie Thompson, to join the
Congressional Kidney Caucus. She also cornered a
congressman from Louisiana to request funding for the
Organ Donation and Recovery Act. “I can’t even vote for
him and he knew it!” reports Price, 55.
The Foundation was also honored with the ringing of the NASDAQ Closing Bell on World
Kidney Day, and our message, NKF logo and 30-second TV spot were given prominence on
the NASDAQ screen in New York City’s Times Square throughout the day. The Closing Bell
Ceremony was covered by CNBC and Bloomberg Television.
Photo: Marc S. Levine
It was a true home run for health when NKF teamed up with the New York Mets for a
special Kidney Awareness Day at Shea Stadium, hosted by NY Mets outfielder Cliff Floyd
during an August home game. Floyd, who knew about his dad’s history of kidney disease,
made sure to get himself tested and took steps to keep his early kidney disease under
control. He taped a TV spot comparing his all-out efforts to perform at the highest levels
on the field, to that of his kidneys’ less than stellar performance. He encouraged others
to check out their kidneys before it becomes too late. The spot was played repeatedly on
the stadium’s Jumbotron during Kidney Awareness Day, and NKF provided informational
brochures to thousands of fans seeking to learn more.
profile
KIDNEY DAY AT SHEA
10
11
When she was just 23, Price’s kidneys began to fail. “To
this day, no one knows why,” she says. Though stunned,
Price paid close attention to her doctor’s orders, exercised
and ate properly, and managed to forestall dialysis until she
was 46. Three years later in 1999, she received a transplant
at the University of Mississippi Medical Center. Since then,
there isn’t much Price, a mother, grandmother and regional
manager for BellSouth, won’t do on behalf of the National
Kidney Foundation. As an African-American—a population
disproportionately affected by kidney disease—Price does
extensive outreach work. She speaks at community
meetings and health fairs, as well as from church pulpits.
She also visits dialysis centers to encourage those who
need transplants to move forward, even if they are afraid.
“They see how good I look, how healthy I am. That’s
so important to see a living, breathing example of a
transplant recipient, particularly an African-American, like
them,” she says.
What’s more, the woman who prefers marathon shoe
shopping to sports has even competed in the U.S.
Transplant Games. “I bowl,” she says, laughing, “and I’m
really lousy at it.”
What Price excels at is feeling gratitude for being alive.
“In the deepest moment of despair a family who lost
their 13-year-old son donated his organs and gave me and
others a chance at a normal life,” she says. “How could I
not give back?”
FROM THE 74-YEAR-OLD FARMER IN
BANCROFT, IDAHO, TO THE 18-YEAROLD HIGH SCHOOL STUDENT IN BATON
ROUGE, LOUISIANA, THE NKF’S PATIENT
SERVICES PROGRAMS REACHED OUT
PATIENT SERVICES
TO MILLIONS OF AMERICANS WITH
CHRONIC KIDNEY DISEASE BY OFFERING
EASY ACCESS TO VITAL HEALTH
INFORMATION, ONGOING PERSONAL
SUPPORT AND LIFE-SAVING PROGRAMS.
12
22
13
23
Photo: Erica Berger
PATIENT SUPPORT AND EMPOWERMENT
Chronic kidney disease (CKD) can often disrupt the flow of family life and derail
personal dreams with lengthy, ongoing treatment and related medical issues that
constantly arise. NKF Affiliates around the country are working to empower patients
and families to achieve their life and career goals and enjoy socialization. Summer
camp programs are offering ways for kids and adults with CKD to reclaim a normal
life in the face of kidney disease. College scholarship programs are doing the same
for people on dialysis who are seeking retraining. When emergency strikes and
power is about to be shut off, medication is running out or the eviction notice is on
the door, NKF Affiliates can be relied upon for financial assistance.
KATRINA AFTERMATH
When Hurricane Katrina devastated the Gulf Coast region, local residents and
fellow Americans set about trying to repair physical damage and destruction in
order to return a sense of normalcy to daily life. Renovating homes proved easier
than rebuilding traumatized psyches, especially among those whose personal
and professional survival depended on receiving and providing life-saving dialysis
treatments in the face of a natural disaster. NKF’s “People Like Us: Stepping
Back into Life” initiative is addressing the trauma, despair and depression
plaguing the Gulf Coast through a CD-ROM program that offers support and
coping tools for patients. The program, to be delivered by professionals, will
reach thousands of people on dialysis, as well as kidney care professionals in
the New Orleans, Baton Rouge, and Lafayette areas. Every single dialysis social
M A RY W E N D T
“I am so impressed by my patients... I often think
they help me cope more than I help them.”
worker in the state will receive one as well.
DIALYSIS EDUCATION
Mary Wendt listened as the woman spoke haltingly of her
feelings of sadness since Hurricane Katrina had devastated
her hometown and upended her life. “I’ve got to stop talking about all this loss or I’ll cry,” the woman said quietly.
Wendt, a dialysis social worker in New Orleans, comforted
the normally stoic patient by saying, “This is the place to
cry! Right here!” Though Wendt is kindly and soft-spoken,
she also happens to be a veteran social worker who can
cut through the thicket of bureaucracy like a chainsaw if
it means securing financial aid and other services for her
dialysis patients.
NKF Affiliates offered peer mentoring programs to help new patients adjust to life
on dialysis by pairing them with seasoned patients who could share the benefit
of their own personal experience and offer encouragement and support.
FAMILY FOCUS
Photos: Erica Berger
The kidney community’s quarterly newspaper, Family Focus, continued to address
key issues that touch the lives of people on dialysis and their families. This year’s
articles focused on Medicare Part D coverage for dialysis, quality of life issues
and disaster preparedness. The newspaper was mailed to every dialysis unit in
the country, as well as to 42,000 home subscribers.
profile
Dialysis is a life-saving treatment for hundreds of thousands of people with
kidney failure, yet the process itself can be complex and misunderstood. NKF’s
Patient and Family Council has long been dedicated to tackling issues affecting
individuals with kidney disease and their families. This year, it developed
nationwide education initiatives to help people facing kidney failure understand
the different options available to them, as well as the safest and most effective
ways to receive treatment.
14
15
Katrina has left behind the sort of emotional damage
that requires extraordinary training and care. That’s why
Wendt, former president of the Foundation’s local Council
of Nephrology Social Workers, has helped organize the
National Kidney Foundation’s “People Like Us: Stepping
Back into Life” program, which was created to help those
on dialysis cope with lingering post-Katrina trauma. Social
workers throughout Louisiana have received kits that
include a two-part audio CD, along with a facilitator’s guide
they can use in a classroom setting. Additionally, patients
undergoing dialysis can listen individually to a CD about
how to get through depression and hear people like themselves tell their personal stories.
“Many have lost their homes, family, friends, churches, even
transportation to and from the dialysis clinic,” says Wendt, a
New Orleans native. ”They still have to deal with a chronic
illness that requires a healthy diet, medications and dialysis.
It’s staggering. Most don’t identify what they’re feeling as
depression. They say they’re ‘tired’ or ‘stressed.’ We are
so grateful for anything that helps us help them to cope.”
Wendt, whose home received only minor damage, says she
is profoundly moved by the patients, whose fortitude sets an
example for the doctors, social workers and staff. “I am so
impressed by my patients,” she says. “They are poor, they’ve
been shaken to their core, and with all the stress and the
loss of their support systems, they aren’t whiners. I often
think they help me cope more than I help them.”
EVERY 11 MINUTES A NEW
NAME IS ADDED TO THE ORGAN
TRANSPLANT WAITING LIST AND
ORGAN AND
TISSUE
DONATION
EVERY DAY 18 PEOPLE DIE WHILE
WAITING. THROUGH AWARENESS
ACTIVITIES AND SUPPORT,
THE NKF’S ORGAN DONATION
INITIATIVES AIM TO CHANGE
THOSE NUMBERS.
16
17
Photo: Erica Berger
THE NATIONAL KIDNEY FOUNDATION
U.S. TRANSPLANT GAMES
Photo: Eric Miller
The life-saving power of organ donation was portrayed in vivid color this summer as more
than 1,200 transplant recipient athletes from around the country played on their own
field of dreams at the Olympic-style 2006 U.S. Transplant Games in Louisville, Kentucky.
Together with their families and organ donors, over 7,000 Games participants showcased
the success of transplantation and encouraged organ donation, as they competed for
medals in 12 different sports. At the Donor Recognition Ceremony and the Living Donor
Recognition Event, they honored those who gave the gift of life.
Through the participation of high-profile national spokespeople, the event drew widespread
media attention to the organ and tissue donor cause. The inspirational personal stories of
Photo: Eric Miller
those American heroes whose lives were touched by organ transplantation, either through
giving or receiving the gift of life, were highlighted through coverage by the Associated
Press; CNN; National Public Radio; CBS TV; USA Today; Good Housekeeping, Parents,
Runner’s World, Prevention magazines and numerous others.
DONOR AWARENESS CAMPAIGNS
The organ donor message was broadcast throughout the year with the NKF’s Donate Life
Month Campaign in April and the Holiday Gift of Life initiative at year-end. Both promotions pointed out the weightiness of the number 91,000, especially as it measured lives
E M I LY B I O N D I
on the waiting list for organs. The holiday campaign urged consumers to take a break
from traditional gift-giving with a new tradition that wouldn’t break the bank: signing up
Photo: Eric Miller
“My doctor calls me when young patients
need a transplant, and I go and talk to them.”
for organ donation. This gift is in the true spirit of personalized, holiday giving that doesn’t
cost a cent. The Foundation reminded Americans that one such gift could ultimately make
many people happy, since one organ and tissue donor has the potential to save 50 lives.
IMPROVING TRANSPLANT CARE
Two NKF initiatives focused on improving the care and health of transplant recipients over
the long term so that they can preserve the gifts bestowed upon them by organ donors.
The first was a global conference that laid the groundwork for a new clinical practice guideline on transplantation, funded by the NKF Board of Directors, and the second was a study
The conference, initiated by Kidney Disease: Improving Global Outcomes (KDIGO), an international organization managed by the NKF, focused on reducing the need for second transplants through development and implementation of guidelines. These guidelines will help
doctors around the world manage complications associated with kidney transplantation and
help recipients live long and healthy lives.
This year, the NKF also launched a long-term initiative addressing levels of awareness among
profile
investigating the awareness of cancer risk among transplant recipients.
transplant recipients about their increased risk of cancer, and providing education to health care
Photo: Emily Newell
professionals and recipients about the best ways to prevent and treat post-transplant cancer.
18
19
As Emily Biondi racked up medals at the recent U.S.
Transplant Games, her father Norman watched with pride
and bemusement. Emily, 23, won silver medals in the
100-meter backstroke, the 5K and the 200-meter run, and
a gold in the long jump. Her father, a financial planner in
Ellicott City, MD, shook his head. “This was a girl who
refused to go out for high school sports because of that
sweating thing,” he reports wryly.
Emily is now majoring in health administration and public
policy at the University of Maryland, Baltimore County, and
plans to work in the area of transplantation or stem-cell
research. On weekends, Emily performs at a dinner theater.
On Friday nights and Sundays she is Violet Bick in “It’s a
Wonderful Life,” and on Saturdays she is Glinda in “The
Wizard of Oz.” Last season, she played the lead role in
“The Little Mermaid.”
That’s the thing about Emily—she endures, overcomes and
soars, all seemingly without breaking a sweat. Near the
end of her sophomore year at Florida Southern College,
Emily, a theater and dance major, began to feel so depleted
that she could barely get out of bed. Her mother brought
her home and eventually doctors discovered the otherworldly fatigue was kidney failure. Emily underwent a blood
transfusion and began dialysis. At just 19, she needed
a kidney transplant. Her father came to the rescue with
“Lefty,” what Emily calls his donated kidney. Lefty has not
only saved Emily’s life, but has transformed it.
Emily has taken on a new real-life role as well. “I’m sort of
a preacher and poster child for transplantation,” she says.
“My doctor calls me when young patients need a transplant, and I go and talk to them. I’m also very involved with
Team Maryland, the state Transplant Games Team. It’s a
great group.”
Better than the medals, Emily says, was the honor of
having sung at the closing ceremonies of the Transplant
Games: “It was a fun place to shine and to show that
people with organ transplants don’t have to give up. They
can live great lives!”
DELIVERING CUTTING EDGE
CLINICAL PRACTICE GUIDELINES
PROFESSIONAL
EDUCATION
AND COMPANION TOOLS SO THAT
KIDNEY PATIENTS CAN BENEFIT
FROM THE LATEST SCIENCE WAS
A MAJOR FOCUS THIS YEAR.
20
22
21
23
Photo: Erica Berger
NKF’S KIDNEY DISEASE OUTCOMES
QUALITY INITIATIVE (KDOQI)
KDOQI, now in its 10th year of providing evidence-based recommendations to improve kidney patient care, published new clinical practice guidelines on anemia in
chronic kidney disease (CKD) last spring. These are the first guidelines to address
diagnosis and management of anemia at all stages of kidney disease. They advocate
that all CKD patients be evaluated for anemia—one of the complications of CKD
that is most responsive to treatment—and that hemoglobin levels be maintained
above 11 grams per deciliter. In addition, the KDOQI clinical practice guidelines for
hemodialysis adequacy, peritoneal dialysis adequacy and vascular access were updated and published in July 2006. This represented the second update of these landmark guidelines, which have measurably improved outcomes as increasing numbers
of patients have reached target levels established by KDOQI. According to recent reports from the United States Renal Data System, survival rates for dialysis patients
have improved since the KDOQI guidelines were originally released in 1997. The latest data shows a 6.5% increase in five-year survival rates for hemodialysis patients
and a 14% increase in five-year survival rates for peritoneal dialysis patients.
Based upon these KDOQI publications and through the collaborative dedication
of NKF volunteers, NKF’s Kidney Learning System (KLS)™ developed innovative
tools and informative materials to help physicians and health care professionals
L E S L I E S P RY
implement the recommendations. These include the Dialysis Care Package, a
specially designed boxed-set of materials based on the KDOQI 2006 Updates for
"It’s all about public education, one more way to give people
knowledge. Give them information that they pay attention to
and learn from, and you can save lives. That’s what I want."
Hemodialysis Adequacy, Peritoneal Dialysis Adequacy and Vascular Access; Anemia in CKD; and Cardiovascular Disease in Dialysis Patients. This comprehensive
educational package consists of manuals, handbooks, patient brochures in both
English and Spanish, a CD-ROM and a wall chart.
Leslie Spry is every kidney patient’s dream doctor. A man
of science, except for a boundless faith he places in his
beloved Cornhuskers, the former farmboy from Broken
Bow, Nebraska, is a top notch nephrologist who also happens to be a great guy.
KLS developed additional new materials that will help professionals provide
patient education, and offered a wide range of innovative continuing medical
education and continuing education (CME/CE) opportunities on a variety of topics
including diabetes, cardiovascular disease, anemia, mineral and bone disorders
and infectious diseases. CME/CE is developed using multi-media, which expanded this year to include downloadable mobile technology accessible via health care
KLS programs were also featured as live symposia, clinical meetings, on-line
Webcasts, CD-ROMs and monographs. CME/CE activities are accredited for all
disciplines of the health care community, ranging from pharmacists and nurses to
dietitians and social workers to dialysis technicians and nephrologists. In addition,
KLS addressed the needs of its target audiences by increasing CME/CE opportunities for doctors of osteopathy, family practice physicians, advance practice
Photos: Erica Berger
nurses and physician assistants.
profile
providers’ personal digital assistants, or PDAs.
22
23
“I admire my patients. They are very brave folks,” says
Spry, 55. He is the medical director of the Dialysis Center
of Lincoln, Nebraska, where he treats patients and participates in research and innovative projects to help improve
dialysis care. “They live with a chronic disease. That’s no
small thing. My role is to help them cope, to offer them
information and care that will make their lives easier.”
For Dr. Spry, a member of the National Kidney Foundation
since 1981 and a frequent media spokesman for the organization, that means educating all Americans about kidney
disease. In the early ’80s, Spry developed a patient education effort in St. Louis. It was the seed from which NKF’s
“People Like Us” program grew. He helps the NKF develop
and review brochures and publications for professionals,
patients and the general public. In other words, he wrings
out the medical jargon and rings in patient-friendly prose.
“I don’t talk about “glomerulus” when I mean
“kidney filter,” he says, laughing. “I’m a translator.” And,
at heart, a teacher. He is on the steering committee for
an exciting NKF project that will educate patients about
dialysis and transplantation through comic strip characters
based on real life patients and their stories.
“People are frustrated and frightened by dialysis, transplants,
the bureaucratic medical maze,” he says. “Facts are important, but if you give people facts in the form of stories they’ll
mean something. They will remember them. It’s all about
public education, one more way to give people knowledge.
Give them information that they pay attention to and learn
from, and you can save lives. That’s what I want.”
EMPOWERING OUR CONSTITUENTS
TO SPEAK UP WHEN IT COMES TO
THEIR OWN HEALTH CARE AND
ENSURING THAT THEIR VOICES ARE
HEARD BY THE U.S. CONGRESS IS THE
ADVOCACY
FOCUS OF NKF’S ADVOCACY EFFORTS
AND THE “PEOPLE LIKE US” INITIATIVE. AS A RESULT, LAWMAKERS PAID
INCREASED ATTENTION TO KIDNEY
DISEASE AND ORGAN DONATION
ISSUES THIS YEAR.
24
25
Photo: Erica Berger
NKF’S “PEOPLE LIKE US”
Through the “People Like Us” program, patient advocates built support for the
Foundation’s legislative priorities by contacting and visiting their U.S. congressional delegations to request increases in vital research funding. They also
advocated for public policies that advance organ donation and kidney disease
education. NKF helped make this happen by providing ongoing advocacy training for patients on issues such as preparing for congressional visits, the roles of
Photo: Lauren Burke
key congressional committees and NKF public policy priorities.
In April, the Foundation joined forces with 12 other transplant-related organizations to urge Congress to fund organ donation programs as part of the Organ
Donation Recovery and Improvement Act of 2004. The daylong “fly in” included
visits to 50 House and Senate offices, where provisions including financial assistance to living organ donors, and extension of Medicare coverage for vital immunosuppressive drugs for kidney transplant recipients, were discussed.
Fewer than half of new kidney failure patients receive the information they
need to fully understand their diagnosis and the various treatment options available to them before beginning dialysis treatment. In a valiant attempt to change
those numbers, “People Like Us” advocates from across the country flew to
Washington, D.C., in June, urging lawmakers to support the Kidney Care Quality
J I M M C D E R M OT T
and Improvement Act. This comprehensive legislation would provide Medicare
coverage of pre-dialysis education, and ensure that Medicare’s payment for dialy-
“Kidney patients look to political leaders and
we must not let them down.”
sis would keep pace with inflation. The advocates participated in nearly 30 congressional meetings. Their hard work paid off when Congress responded in late
December by passing a provision that would increase the rate of Medicare payment for dialysis treatment.
When it comes to power and passion, kidney patients could
not dream up a better advocate than U.S. Representative
Jim McDermott (D-WA), now serving his 10th term in
Congress. His philosophy of public service is, “We can transform common dreams into the common good.”
Persistence paid off once again this year when the Centers for Disease Control
and Prevention (CDC) awarded a grant to NKF for the implementation of a chronic
kidney disease (CKD) screening program on both the federal and state levels. The
program, which was established in 2006, targets Americans at high risk of CKD in
Photo: Lauren Burke
profile
order to detect it early on and improve patient outcomes.
26
27
The first member of his family to graduate from college,
McDermott, a Seattle resident, has served his country in a
multitude of ways. He’s a physician with a specialization in
psychiatry, and he has served in the U.S. military. In 1987,
after 15 years in the Washington state legislature, he left politics and headed to Zaire, where he provided psychiatric services to Foreign Service, USAID and Peace Corps workers.
Congressman McDermott is particularly proud of the
Northwest Kidney Center in Seattle, created by his friend,
the kidney dialysis pioneer and inventor of the Scribner
shunt, Dr. Belding Scribner. Together, Congressman
McDermott and the Center have shown the advantages
of home hemodialysis and more frequent dialysis therapy.
Congressman McDermott has introduced legislation that
would promote this as a member of the Ways and Means
Committee. “Kidney patients look to political leaders and
we must not let them down.”
In 2002, Congressman McDermott established the
Congressional Kidney Caucus with Congressman Mark Kirk
(R-IL). It is his way of educating his colleagues about the disease and rallying lawmakers to allocate funding for research,
prevention and emotional and financial help for those on
dialysis or awaiting transplants. In the future, he hopes the
Caucus will reach out to new Members of Congress, to educate them about the numerous issues kidney patients face,
and the responsibility of political leaders to take positive
action on their behalf.
“We each have our heroes. Gandhi is one of mine. Gandhi
said, ‘Be the change you want to see in the world.’ Those
are words to live by and a philosophy to guide us in making
laws that affect the lives of the American people.”
WHAT CAUSES KIDNEY DISEASE? HOW CAN
WE PREVENT ITS PROGRESSION TO KIDNEY
FAILURE? AND, WHAT CAN WE DO TO
IMPROVE QUALITY OF LIFE FOR THOSE WITH
KIDNEY DISEASE TODAY? NKF’S RESEARCH
PROGRAM AWARDS NEARLY $3 MILLION
RESEARCH
ANNUALLY TO THE BRIGHTEST MINDS IN
SCIENCE SO THAT EVERY DAY WILL BRING
US CLOSER TO FINDING THE ANSWERS TO
THOSE QUESTIONS. MORE THAN 60 AWARDS
ARE GRANTED THROUGH NKF’S RESEARCH
FELLOWSHIP, YOUNG INVESTIGATOR AND
CLINICAL SCIENTIST PROGRAMS.
28
29
Photo: Erica Berger
CARDIOVASCULAR DISEASE
Cardiovascular disease (CVD) is much more common among people with kidney
disease than it is in the general population. In fact, CVD is the leading cause of
death among kidney patients. The causes of CVD in kidney patients are still being
investigated. Denis Glenn, MD, PhD, is an NKF Research Fellow at the University
of California at San Francisco. He is exploring the possibility that decreased levels of active vitamin D seen in many kidney patients may be an important factor
in their increased risk for CVD. Earlier studies suggested that vitamin D may act
directly on heart tissue and may have a protective role in heart failure. Dr. Glenn’s
findings may lead to new treatment strategies for CVD in kidney disease.
HIGH BLOOD PRESSURE
High blood pressure is a leading cause of both heart disease and kidney disease. It is the primary diagnosis for a fourth of the patients whose kidneys fail
each year in the U.S. However, the causes of high blood pressure are largely
unknown. Julie Goodwin, MD, an NKF Research Fellow at Yale University Medical
Center, plans to investigate the role of certain drugs known as steroids in causing
or exacerbating elevated blood pressure. Dr. Goodwin’s study will involve blocking
steroid receptor sites in specific tissues such as the kidneys and blood vessels.
She hopes to determine where steroids have the greatest effect on blood pres-
R O B Y N C U NA R D
sure and what treatment strategies could be used to prevent this problem.
“The NKF has given me the most important gift:
protected time. Research is impossible without it.”
VASCULAR ACCESS
When kidney disease progresses to kidney failure, treatments such as transplantation or dialysis are needed to maintain life. Hemodialysis is the most common
form of kidney replacement therapy. Vascular access, or entrance to the blood-
Robyn Cunard had made up her mind to become an
engineer, but when life whispered a different plan on a
roadside in Upstate New York, she paid attention. At age
16 she became the youngest member of a volunteer
ambulance corps in tiny Goshen, New York. “We were
called to a tanker accident and the guy was pinned inside,”
she recalls. “My job was to hold his hand while the fire
guys came in to extract him. It felt right holding his hand,
comforting him.” The aspiring engineer was no more. Her
future was now in medicine.
stream, is needed to allow the patient’s blood to travel through a special filter
called an artificial kidney for removal of impurities from the blood. Vascular access
is an important factor in how well patients do on hemodialysis.
This year, two NKF Research Fellows at the University of Alabama at Birmingham,
Jimmy Lee, MD, and Ivan Maya, MD, are exploring ways to improve the use of
different types of vascular access. Dr. Lee’s study focuses on arteriovenous fistulas (AVFs), which are the preferred type of access for most hemodialysis patients.
Dr. Lee plans to perform ultrasound exams of AVFs at one month after placement
to determine whether this will make it possible to increase the number of AVFs
that mature and are used successfully.
Dr. Maya’s study focuses on grafts, the second best type of access. His observations are aimed at finding out whether treatment of clotted grafts is more successful when angioplasty, a procedure to open blocked vessels, is combined with
placement of a wire mesh tube, or stent, at the affected site.
profile
Photos: Erica Berger
30
31
These days, the 39-year-old nephrologist is a gifted
researcher and recipient of many prestigious awards,
including two National Kidney Foundation grants. A staff
physician at the Veteran’s Administration Health Care
System San Diego and an assistant professor of medicine
at the University of California, San Diego, she devotes her
time to researching PPAR ligands. Cunard believes that
drugs already taken by many people to treat diabetes and
high lipids/cholesterol may also help those with kidney disease. She has discovered that PPAR ligands are anti-inflammatory agents, which help fight infections in the body. In
her experiments, these ligands have slowed the progression of inflammatory kidney disease in mice.
“I love this research,” she says. “It’s very exciting because
it’s practical and clinically relevant.” Cunard, who lives with
her journalist husband and their two babies, says she could
not have done this research without the NKF. The first
grant she received, in 2002, paid for a lab technician. “She
is still with me, I’m proud to say,” Cunard reports, then
adds wryly, “though I’m very hands-on.”
The NKF’s most recent grant, the Clinical Scientist Award,
pays part of Cunard’s salary, enabling her to concentrate on
science. “The NKF has given me the most important gift:
protected time,” she says, gratefully. “Research is impossible without it.”
THIS YEAR, OUR FUNDRAISING ACTIVTIES
WERE ALL ABOUT PARTICIPATION.
WHETHER THEY WERE EMPLOYEES, FAMILY
MEMBERS OF KIDNEY PATIENTS OR
GOLFERS, NKF’S DONORS EXPERIENCED
FUNDRAISING
FIRSTHAND THE LIFE-SAVING IMPORTANCE
OF THE FOUNDATION’S FAR-REACHING
PROGRAMS. NEW ALLIANCES WERE FORGED,
GRASSROOTS FUNDRAISING GREW
STRONGER AND CORPORATE PARTNERSHIPS
WERE STRENGTHENED AND EXPANDED.
32
22
33
23
Photo: Erica Berger
CB RICHARD ELLIS CARES
In 2006, NKF was chosen by CB Richard Ellis (CBRE), a global market leader in
real estate, as a partner for CBRE Cares, their inaugural national corporate philanthropy program. This Fortune 500 company with over 350 offices nationwide
encouraged its 10,000 employees to contribute financially and to become personally involved with its partner organizations. NKF and its Affiliates participated in
over 50 CBRE Cares campaign kick-off events held around the country. The new
corporate partnership is an exciting opportunity for the Foundation to join forces
with a dynamic global organization, and to gain more volunteers, more awareness
and more funds to support NKF’s life-saving programs.
KIDNEY WALKS
With 72 events held this year in cities around the country, the Kidney Walk has
grown tremendously in popularity and success. New initiatives in corporate sponsorship recruitment and building of the Walk team structure attracted 20,000
walkers and generated nearly $3 million.
GOLF CLASSIC
The National Kidney Foundation Golf Program transitioned to an independent,
newly branded platform in 2006. Thousands of golfers participated in 30 NKF
Golf Classic signature tournaments that were conducted throughout the country.
Along with our continued partnership with Pebble Beach Resorts, NKF’s Golf
Classic program secured new national sponsorships with PING and Tourneau, and
a media partnership with Cingular Wireless.
R OY M A L K I N
“It’s the NKF’s mission, its proactive prevention programs and the fact that each day
the NKF provides ‘real time’ assistance to those who suffer from kidney disease.”
When Roy Malkin was asked to be the Honorary Chairman
of the 2006 Kidney Walk in Minneapolis, he agreed, but with
one caveat: “The local NKF Division had established a fundraising goal of $75,000,” recalls the 61-year-old president and
CEO of Minnesota-based Minntech Corporation. “I said that
was totally unacceptable. We’ve got to raise in excess of a
quarter of a million dollars!”
HEALTHY KIDNEY 10K
KIDNEY CARS PROGRAM
Photo: Rich Mullane
Once again, used cars breathed new life into NKF’s myriad of projects through
the Kidney Cars Program. This nationwide vehicle donation program continued to
see improvements in net returns as a result of new online marketing tactics that
have led to a dramatic increase in Internet-based donations. Currently, more than
60% of donations are made on-line, a practice that reduces costs and increases
profit. This year, more than 40,000 cars became Kidney Cars, generating nearly
$12 million to support our life-saving programs.
profile
More than 6,000 runners teamed up to learn about kidney health, while raising
funds for the NKF as part of the second annual Healthy Kidney 10 K Run. The
race, held in Central Park in New York City, was sponsored by the Embassy of the
United Arab Emirates (UAE) and raised over $200,000. The Healthy Kidney 10K
pays tribute to the former UAE president, Sheikh Zayed Bin Sultan Al-Nahyan,
who benefited from American expertise, knowledge and research when he
received a kidney transplant in 2000.
Photo: Acey Harper
34
35
And Malkin meant it. This first-ever Kidney Walk brought
in $275,000. He credits his 375 employees for the core of
that success. “We mobilized our team and the rest is history,” he says proudly. “Minntech Magic,” as the walk team
was dubbed, began its efforts five months in advance.
Employees were able to buy extra vacation days for a Kidney
Walk donation of $50 per day for hourly employees, and up
to $175 for senior executives. Every subsequent month leading up to the event brought a different team-building, fundraising activity such as the chance to dunk the executives,
Malkin included, in a giant water tank.
Malkin, who runs on equal parts enthusiasm and pragmatism, was thrilled with Minntech Magic’s success, which
raised over $145,000 for the NKF. But Malkin insisted on
giving the NKF far more than just money. His team members created a Corporate Walk Team prototype program
complete with CD. “It’s a mission for us,” he says. “We want
other companies throughout the country to say, ‘We can do
this, too. We can create the same level of enthusiasm and
achieve a very positive outcome.’” Malkin added, “We’ve
proven that you don’t have to be a huge company to be
extremely effective!”
Malkin presented his prototype program at the NKF’s
Kidney Walk Academy, an annual training program for those
who organize local Kidney Walks. “I was pleased with the
response and I volunteered to go anywhere they needed me
to get the word out,” he said.
A former Vietnam era combat and test pilot whose hobbies now include building and flying seaplanes, Malkin
also has personal reasons for supporting the NKF. His wife
received a kidney from one of their daughters, and their
other daughter was born with only one kidney. “But that by
no means is the driving factor for my involvement with the
National Kidney Foundation,” says Malkin. “It’s the NKF’s
mission, its proactive prevention programs and the fact that
each day the NKF provides ‘real time’ assistance to those
who suffer from kidney disease. Those activities and many
more make all of us very pleased to be a small part of such
a valuable endeavor.”
OUR SUPPORTERS
CORPORATE PARTNERS
The Ada DeBold Society
Our corporate and organizational partners are critical to our success in developing
and implementing world-class educational intiatives, programs and events. This year,
contributions from national corporate partners supported NKF in the development of
clinical practice guidelines for physicians, as well as community-based programs for
those at risk for kidney disease and those already suffering from kidney disease.
PLATINUM
BRONZE
SUPPORTER
Abbott
Siemens Medical Solutions
Diagnostics
Baxter Healthcare
Amgen
Novartis Pharmaceuticals
Corporation
Genentech, Inc.
C.B. Richard Ellis
Lifescan, Inc.
Jewish Hospital &
St. Mary’s Healthcare
Ortho Biotech Products, L.P.
Luipold Pharmaceuticals, Inc.
Mayo Clinic
Roche Pharmaceuticals
Musculoskeletal Transplant
Foundation
Phi Sigma Sigma Foundation
Wyeth Pharmaceuticals
Nabi Pharmaceuticals
OceanSpray Cranberries, Inc.
GOLD
Genzyme
Pfizer Inc.
Astellas Pharma US, Inc.
Embassy of the United
Arab Emirates
Takeda Pharmaceuticals
Tourneau
FRIEND
CONTRIBUTOR
Atlas Telecom
SILVER
Satellite Healthcare, Inc.
Sanofi-Aventis
GlaxoSmithKline
Shire
The Ada DeBold Major Giving Society represents individuals and organizations
who have made generous contributions to further the work of the National Kidney
Foundation in the 55-year-old tradition of Mrs. Ada U. DeBold, one of the founder’s of
the National Kidney Foundation.
Bristol-Myers Squibb
Cingular Wireless
Fresenius Medical Care
International Golden Group
Merck & Co., Inc.
Keryx Biopharmaceuticals, Inc.
Ross Products Division
Abbott Laboratories
KOS Pharmaceuticals
Watson Pharma, Inc.
Northwest Airlines
AlGeco
Brown-Forman Beverages
Code Contracting Company
Jumeirah
LifeTrac Transplant Network
Lockheed Martin
Omeir Bin Youssef & Sons
The Wendy Marx Foundation
for Organ Donor Awareness
Mediflex
Pebble Beach Company
PING
United Resource Networks
36
37
Abbott Laboratories Renal Care
Alabama Organ Center
Stuart & Louis Abramson
University of Alabama
Charles E. Alfano
Susan Alfano
Brad Allen
Joe Andres
Margaret R. Anson
E. Arditti Charitable Foundation
David Ashbach, MD
Jon & Helaine Ayers
Greg Baron
Stephen T. Bartlett, MD
Rod & Tina Bascom
Maureen Basney
Susan Baumgardner
Andrew N. Baur
Liz Beck
Richard & Lisette Bernard
Boren Family Foundation
Louis Borick
D. Stuart Bowers
Christine Brauss
Susan Patla Brereton
John Brockington Foundation
John Broderick
David G. Bucher
James Burke, MD
Bob & Wauneta Burkley
Phillip & Karen Burrell
Sam R. Buxton, III
Drs. Jeanne & Chuck Cangro
John & Sonya Cattelan
Estate of Samuel A. Clauss
James Clayton & Clayton Family Foundation
Dr. Arthur & Susan Cohen
Sue Ann Collins
Brian & Carol Condon
Anna & Charles Conigliaro Foundation
Curtis & Jewel Cooke
Peter & Alkene Cooley
W. Michael Craig
Tim Craig
Dan & Jeanne Cuda
Brayden Curley
Paul S. & LaVerne D. Curley
Glenn M. Cusick
Brad & Rosemary Danielson
Ronald DaVella
Denise & John D’Avella
John I. Denny
Shirish Desai
Bob & Alie DiCarlo
Dickson Foundation, Inc
Brian Dilsheimer
Paul & Kathleen Dioli
David R. Doebler
Mary-Susan & Brian Donhauser
Roy Dorsey
Richard Drake, MD
Marcy Edmiston
Julia Esdale
Curt & Cindi Fankhauser
Kathy & Ken Felton
Margie L. Fort
Albert A. Fox
Dr. & Mrs. K. Trevor From
William Lee Frost
In Memorium Stella Green Gaignard
James W. Gallaher
Christopher T. & Terri P. Gallu
SFC Charitable Foundation, Inc.
Gelfand, Rennert, & Feldman
Terrence & Julie George
Steve & Mindy Geppi
Thomas & Debra Gillespie
Kenneth Glen Family Foundation
Goodman Family Foundation
Myra Goodman Smith
Rebecca Grahlkey
Mr. & Mrs. Kenneth Gray
Anne W. Griffin
Nancy J. Gritter, MD
Gerald Groggel, MD
Milton & Alice Gross
Peter & Alkene Halstead
Kevin & Patricia Hannifan
Kimberly & Eric Hathaway
Glen Hayashida
Daniel H. Hayes, MD
Mr. & Mrs. Jonathan Hazman
Al Hemond Trust
Mary Kay Hensley
Anne Hetrick
Richard L. & Donna F. Hill
Kevin N. Hill
HK Management
Trevor W. & Tracy L. Hoffman
Charlotte Johnson Hollfelder Trust
Paul Holloway
Leonard Hopkins, Jr., Esq.
Dr. & Mrs. Fred E. Husserl
John Imbriale
Dr. Donald Indadomi
Paul & Beth Jensen
Hazel Johnson Estate
Harriet Jones
Mr. & Mrs. Richard Jones
Siegfred Kagawa
Dr. Elaine Kamil
Denice K. Keliikoa
Leo & Sharon Kilcullin
George W. King
Thomas M. Kinkead, MD
Dr. Edward & Joanne Kraus
Herb Kritz
Rebecca LeClair
John T. Leonard
Wanda C. Lessner
THE HERITAGE CLUB
The Heritage Club, boasting more than 300 members, recognizes the generosity
of donors who have designated NKF as beneficiary of planned gifts. Some have
remembered the Foundation in their wills through bequests, some have named
NKF partial beneficiary of life insurance policies and some have created charitable
gift annuities or charitable remainder trusts.
OUR SUPPORTERS (continuation)
Jay B. Levy, MD
Bill & Meloney Liebler
Walter and Vanita Luckett
Eric Malm
F. Stafford H. Manion
Louis M. & Nancy A. Markwith
Kevin J. Martin, MD
Kevin Martin
Fred Martin
Stephen L. Mason
Mike Masuda
Ralph & Sandra Matteucci
David D. Mayers
John & Jill McAdams
Francis McCusker, MD
Charles McCutchen
Kathleen McDermott
Mrs. W. Randall McDonnell
Helen & Bob McGraw
Dr. & Mrs. William L. McGuffin
Randall McGuire
Tina & John McLaughlin
Barbara J. McQuitty
Carolyn McVitty
Brian Menkhausen
Paul A. Mennes, MD
Estate of Anne J. Miller
Jan Miller & Craig Lending
Brent W. Miller, MD
Rick Mishler, MD
Hayse & Magdalene M. Mitchell
Sharon Moe, MD
Aubrey R. Morrison
Estate of Clarence Moul
Eleanor W. Myers
Mr. & Mrs. Gordon Nahas
Timothy R. & Marilyn M. Neal
Walter R. and Beverly J. Neal
New Orleans Nephrology Associates
John & Nancy Newman
Dr. Roland & Vivian Ng
Jerry, Rachel & Ethan Nichols
Ed Nukala
Payson Oberg, MD
Deborah & Michael O’Connor
Daniel B. Ornt, MD
Robert Otto
Anthony & Janice Parrotta
Larry & Kathy Pearson
Michael J. Pekos
Thomas Peters
The Petrides Family
Jerry L. & Gina Pigsley
C. Polack, MD
Donovan Polack, MD
Lou & Jean Pollock
The Rachuba Family Foundation
Mr. & Mrs. John Randall
Laura I. Raukin, MD
Estate of Eleanor Kreis Reed
Francis Rieger
Rudy Rodriguez, MD
David Roer, MD &
Mary Lizabeth Aquavia, MD
Sally Rosenbaum
Les Rosenthal
Ralph L. Rousseau
Mr. & Mrs. D. Mathias Roussy, Jr.
Jerry G. Runion
Charles E. Schleifer, MD
Ruth Swett Schofield
Scott & Heidi Schuster
Mr. & Mrs. David D. Seifert
Jame & Barbara Selzer
Shaney Construction Company
William Shepard
Laura & John Shmerler
Rosalyn Siegel
Andrew Silverman
Eduardo Slatopolsky, MD
Dr. James & Mrs. Mary Ann Sloand
Larry & Christine Snyder
Dr. Harvey & Miriam Solomon
Patricia S. Spaulding
Sally R. Stafford
The Willie Stargell Foundation
Gerald Stephanz, MD
Stone Family Fund
Stubblefield Foundation, Inc.
Mr. & Mrs. Henry J. Suelau
Stephen Sundheim
Tim Taber, MD
Ingrid Taylor, MD
Patricia Thomas
L. Scott & Marye Otto Thomlison
Nancy Tringali
Ernest & Rebecca Turner
Luis G. & Audrea Uribe
Johnny Walker
Steven L. Walker
Mr. & Mrs. Arthur R. Walker
Dr. Bradley A. & Barbara Warady
Milton Warshaw
James Wasserman, MD
Ronnie & Edna Weaver
Mr. & Mrs. Frank W. Webber
Dr. & Mrs. Phillip P. Weiner
Dr. & Mrs. Matthew R. Weir
Corbin & Kathy White
James F. & Cecily Whiting
Wichita Nephrology Group, PA
Mike Williams
Mr. & Mrs. Michael Duddley Williams, Sr.
James Wilson & Associates
Wolff Shoe Co. Foundation
Paul Wurzer
Roland & Dona Young
Melvin Yudis, MD
Brian & Beth Zorn
Anonymous
38
39
Bobby R. Abbot
Gretchen A. Ackerson, CLU
J. Douglas Adair
Edward J. Amos
Ray D. Amstutz
Arlene Anderson
Robert N. Baker
Marion P. Baker
Dianne P. Barth
Helen L. Bartlett
Joan M. Bayer
Kenneth R. Beesley
Susan K. Benner
Steve & Sally Bieritz
Brenda Borcherdt
Ronald W. Borcherdt
Jacques J. Bourgoignie, MD
Mr. & Mrs. Norm Bowers
D. Stuart Bowers
Ken Bowman
Camille D. Breen
James K. Broughton
Darrell M. Brown
Charlene Brown
Wendy W. Brown, MD
Mr. & Mrs. Scott Buckley
Connie Burnett
Libby D. Buss
Thomas Butler
Mr. & Mrs. James A. Byrnes
Molly Lillis Cahill
M. David Campbell
Kevin P. Carbin, Jr.
Dan Carney
Mary Carpenter
Donna K. Carpenter
Joseph C. Cerney, MD
Mr. & Mrs. Vickers Chambless
Sharon Chinnery
E. C. ‘Sparky’ Clark
Samuel A. Clauss
Jane Claussen
Louise Coates
Mr. & Mrs. Roger E. Coene
Brenda Colby
Allan J. Collins, MD
Lori Collins
Susan B. Conley, MD
Norm S. Coplon, MD
Scott Eugene Cote
Cristin T. Cotton
Missy Crawford
Barbara Cross
Mr. & Mrs. Timothy Crosson
Dan & Jeanne Cuda
Paul S. Curley
Hisham Dado, MD
Rosemary Danielson
Gary W. Davis
Robert Delonis
Sandra DeTar, RD
Ewart E. Dilks
Randall Mark Divelbiss
Mary Ellen Dix
Mr. & Mrs. Bruce S. Dix
Charles A. Drace, Sr.
Marie Drysdale
Max Dubrinsky
Francis Dumler
John L. Dunlap, MD
Carla Duryee
Brenda Dyson
Drs. Gilbert & Rona Eisner
Roy & Mary Ann Ekrom
Mary Jean Emory
Preston A. Englert, Jr.
Karen Englesman
Mr. & Mrs. John Faires
Diane S. Farber
Frank J. Fay
Marcey Feigenbaum
Mr. & Mrs. Milton Feinson
Eben Feinstein, MD
John Feliciano
Thomas B. Ferguson
Maurice Ferriter
Jay S. Finch
John E. Firmin
James L. Fortner
JoAnne Fournier
Irene Fox
Diane French, RN, MPA
Matthew C. Friederichs
Daniel Fulcher
Suzanne Gagne
Terri P. Gallu
Christopher T. Gallu
Nicholas G. Gardner
Warren E. Garling
William Haskell Gates, III
Gandolfo Chianchiano
Jon W. Gilchrist
Thomas & Debra Gillespie
Mida Girogosian
Leonard Gottleib
Gary Green
Stacy & Craig Groff
Mr. & Mrs. Steven Grove
Donna Gwin
Herbert Hawthorne
Terry P. Headley
Mr. & Mrs. Don Heck
Frederick A. Herbert
Amy Jean Hicks
Randy & Leslie High
Elizabeth W. Hildenstein
Richard L. Hill
John Hoag
Roswell & Elizabeth Hoffman Trust
Barbara Hofstein
Patricia A. Hormann
Kathi Huenink
Karen M. Ilstrup
Mark T. & Cynthia A. Jacobson
John Jamian
Susan M. Jaskula
Rafael A. Javier, MD
Paul & Beth Jensen
Charles Jones
THE HERITAGE CLUB (continuation)
Neone Fitches Jones
Kristi M. Jongeling
Sally Joy
Gary & Zeeva Kardos
Naomi Kawakami
Kirsten F. Kelly
Mr. & Mrs. David Kelly
Eleanor F. Kent
Mr. & Mrs. Mel King
George W. King
Karren King, LCSW, MSW, ACSW
Helen W. Kinnaird Estate
Gerald A. Klisz
Susan Knapp
Joel D. Kopple, MD
Robert D. Kranz
Gerald D. Kumin, MD, PC
David R. Lake
Chris Leonard
Gus Levy, CPA
Lawrence Ley
Mildred Lichtig
Mary Lin
Donald E. Linnartz
Bob Loeper
Adella Fernandez Lopez
Mr. & Mrs. Edward M. Luedtke
Mr. & Mrs. Ronald C. Mackenzie
Doreen Mallard
Michael G. Mayer
Kelly Mayo
Linda McCann, RD
Franklin D. McDonald, MD
Thomas P. McDonough
William S. McGarrahan
Lois & Curtis McGinnis
William L. McGuffin, Jr., MD
Bob McGuire
E. Burns McLindon
Carolyn McVitty
Alan C. Mendelson
James A. Mengler
Michael K. Meyer
Marie Minchin
Stella Mlinarevich
Carl A. Modecki
Lynn Kanter Moltz
Charlie Morse
Spero Moutsatsos
Greg Muerchen
Mary V. Murphy
Lawrence Murphy
Timothy R. Neal
Miriam M. Netter
John H. Newman
Fred Nicholas
Wayne W. Nix
Ray Nowacki
J. L. O’Bryan-Wilson
David A. Ogden, MD
Michael C. O’Grady
Daniel B. Ornt
Carmen J. Ortiz-Butcher, MD
Richard D. Osur
Eddie Pannell
Irene E. Panush, MSW, ACSW
Jean Paris
Barbara Parsons
Mary Agnes Paul
Ronald D. Paul
Max & Marcia Perry
Thomas G. Peters, MD
William W. Petty
Jerry L. & Gina Pigsley
Robert Plumpe
Dann Pollard-Stringer
Oliver W. Porter
Nancy L. Post
Wayne E. Postma
Mary E. Powell
Robert Provenzano, MD
Douglas Ray
Roy Re
Elizabeth Reder
Grace J. Reese
Ophie Resor
Beverly Ricardo
Dorothy Ricenbaw
Ivan M. Richards, MD
Hank Rosenzweig, CPA
Mr. & Mrs. Irving B. Ross
Jeanne & Tevis A. Ross
Jorena Rudd
Dr. & Mrs. Lee M. Russell
John G. Ryan
Richard K. Salick
Phil Salick
Harold A. Saul
Phillip A. Schermerhorn, Jr.
Jonathan Schraub, Esq.
Harold D. Schwartz
Len Schwartz
Julie Schweitzer
James O. Selzer
Elizabeth Serge
Roohallah Shafely
Craig B. Shaffer
Glenna Shapiro
Mr. & Mrs. Roy Shea
Dr. & Mrs. Abraham Sherer
Mr. & Mrs. Bill Singleton
Linda Smith-Wheelock
Gary T. Snyder
Phyllis Solof
Kathleen Spillane-Knight
David P. St. Clair
Terrel G. Stanton
Arthur J. Stegall, Jr.
Grace N. and Gerald V. Steinbaugh
Theodore I. Steinman, MD
Ann C. Stivers
Harry B. & Hilda Sugarman
Cynthia J. Terrell
Mr. & Mrs. Roy G. Thompson
Mr. & Mrs. Andrew Townes, Jr.
Mr. & Mrs. Knox Tumlin
Joel G. Turner
Jay L. Turoff
Linda S. Tyler
Fusayo Urakami
Luis Uribe
Mo Vidwans
Prudence Vipiani
James L. Walden
Greg Ward
Jack Weaver
Betty J. West
John E. Wharton
Randy Williams
Mark E. Williams, MD
Henry Wilson
Donald R. Wilson
Dr. & Mrs. James F. Winchester
Deborah Winegard
Elizabeth Witten
Irv Wolper
Suzanne J. Wyckoff
David Yoburn
Rosemary Zeplowitz
Susan Zimmerman
Anonymous
LEADERSHIP
OFFICERS
Chancellor:
Ken Howard
Los Angeles, California
Chairman:
Charles B. Fruit
Atlanta, Georgia
President:
David G. Warnock, MD
Birmingham, Alabama
President Elect:
Allan J. Collins, MD
Minneapolis, Minnesota
Secretary:
Robert V. Ogrodnik
St. Louis, Missouri
Treasurer:
Rodney L. Bishop
St. Louis, Missouri
DIRECTORS
Dear Abby aka Jeanne Phillips
Los Angeles, California
Stephen T. Bartlett, MD
Baltimore, Maryland
Deborah I. Brommage, MS, RD
Mineola, New York
Fred L. Brown, FACHE
Scottsdale, Arizona
Jeffery H. Burbank
Tewksbury, Massachusetts
William Cella
New York, New York
Carl Chaleff
Chicago, Illinois
40
41
John Davis
New York, New York
David A. DeLorenzo
Thousand Oaks, California
Ellen Gaucher, MSN
Des Moines, Iowa
John K. Harrison
Howell, Michigan
STAFF LEADERSHIP
John Davis
Chief Executive Officer
Stephen Bajardi
Chief Operating Officer
Joseph Vassalotti, MD
Chief Medical Officer
Thomas P. McDonough
Bethesda, Maryland
Dolph Chianchiano
Senior Vice President for Health
Policy and Research
David McLean, PhD
St. Paul, Minnesota
Joan Shepard Lustig
Vice President for Field Services
Burl Osborne
Dallas, Texas
Gigi Politoski
Senior Vice President for
Programs
Brian J.G. Pereira, MD, DM
Boston, Massachusetts
William A. Singleton
Washington, D.C.
Mark E. Smith
Richmond, Virginia
Martin Starr, PhD
Plymouth, Massachusetts
Karen Thurman
Dunnellon, Florida
Pedro J. Vergne-Marini, MD
Dallas, Texas
Legal Counsel:
A. Bruce Bowden, Esq.
Pittsburgh, PA
Jo-Ann Vecchione
Senior Vice President for
Organizational Resources
Kerry Willis, PhD
Senior Vice President for
Scientific Activities
Suzanne J. Wyckoff
Executive Vice President
NKF AFFILIATES
National Kidney Foundation
of Alabama, Inc.
334.396.9870
National Kidney Foundation
of Indiana, Inc.
317.722.5640
National Kidney Foundation
of Northeast New York, Inc.
518.458.9697
National Kidney Foundation
of Utah & Idaho, Inc.
801.226.5111
National Kidney Foundation of
the Alleghenies, Inc.
412.261.4115
National Kidney Foundation
of Iowa, Inc.
319.369.4474
National Kidney Foundation
of Upstate New York, Inc.
585.697.0874
National Kidney Foundation
of the Virginias, Inc.
804.288.8342
National Kidney Foundation
of Arizona, Inc.
602.840.1644
National Kidney Foundation
of Kansas & Western Missouri, Inc.
913.262.1551
National Kidney Foundation
of Western New York, Inc.
716.835.1323
National Kidney Foundation
of Wisconsin, Inc.
262.821.0705
National Kidney Foundation of Northern
California and Northern Nevada, Inc.
415.543.3303
National Kidney Foundation
of Kentucky, Inc.
502.585.5433
National Kidney Foundation
of North Carolina, Inc.
704.552.1351
DIVISIONS:
National Kidney Foundation
of Southern California, Inc.
818.783.8153
National Kidney Foundation
of Louisiana, Inc.
504.861.4500
National Kidney Foundation
of Ohio, Inc.
614.481.4030
National Kidney Foundation
of the National Capital Area, Inc.
202.244.7900
National Kidney Foundation
of Maine, Inc.
207.772.7270
National Kidney Foundation
of South Carolina, Inc.
803.799.3870
National Kidney Foundation
of Colorado, Montana & Wyoming, Inc.
720.748.9991
National Kidney Foundation
of Maryland, Inc.
410.494.8545
National Kidney Foundation
of East Tennessee, Inc.
865.688.5481
National Kidney Foundation
of Connecticut, Inc.
860.257.3770
National Kidney Foundation of Massachusetts,
Rhode Island, New Hampshire & Vermont, Inc.
781.278.0222
National Kidney Foundation
of Middle Tennessee, Inc.
615.383.3887
National Kidney Foundation
of the Delaware Valley, Inc.
215.923.8611
National Kidney Foundation
of Michigan, Inc.
734.222.9800
National Kidney Foundation
of West Tennessee, Inc.
901.683.6185
National Kidney Foundation
of Florida, Inc.
407.894.7325
National Kidney Foundation
of Mississippi, Inc.
601.981.3611
National Kidney Foundation
of North Texas, Inc.
214.351.2393
National Kidney Foundation
of Georgia, Inc.
770.452.1539
National Kidney Foundation
of Eastern Missouri & Metro-East, Inc.
314.961.2828
National Kidney Foundation of
South & Central Texas, Inc.
210.829.1299
National Kidney Foundation
of Hawaii, Inc.
808.593.1515
National Kidney Foundation
of Nebraska, Inc.
402.572.3180
National Kidney Foundation
of Southeast Texas, Inc.
713.952.5499
National Kidney Foundation
of Illinois, Inc.
312.321.1500
National Kidney Foundation
of Central New York, Inc.
315.476.0311
National Kidney Foundation
of West Texas, Inc.
806.799.7753
42
43
National Kidney Foundation Serving
the Dakotas and Minnesota
The Dakotas 605.322.7025
Minnesota 952.544.7300
National Kidney Foundation Serving
Greater New York
212.889.2210
DIRECT SERVICES AREAS*:
Arkansas
Nevada
New Mexico
Oklahoma
Oregon
Texas Coastal Bend Area
Washington
* All local programs and services in these areas are
provided directly by the National Organization and can
be accessed by calling 800.282.0190.
Report of Independent Auditors
National Kidney Foundation, Inc.
Balance Sheet
June 30
2006
2005
Cash and cash equivalents
$ 5,004,190
$ 7,557,759
Investments (Note 3)
15,580,868
11,286,563
921,792
817,004
2,203,296
1,863,048
Other receivables (Notes 4 and 8)
645,366
2,197,924
Inventories
548,285
636,309
Prepaid expenses
465,408
833,178
Those standards require that we plan and perform the audit to obtain reasonable assurance about
Fixed assets, at cost, less accumulated
depreciation and amortization (Note 5)
570,072
550,412
whether the financial statements are free of material misstatement. We were not engaged to perform
Other assets
34,049
41,564
an audit of the Foundation’s internal control over financial reporting. Our audit included consideration
Total assets
$ 25,973,326
$ 25,783,761
$ 3,162,357
$ 2,998,452
The Board of Directors
National Kidney Foundation, Inc.
ASSETS
We have audited the accompanying balance sheet of the National Kidney Foundation, Inc. (the
Investments held under split-interest agreements
(Notes 3 and 12)
“Foundation”) as of June 30, 2006, and the related statements of activities, cash flows and functional
expenses for the year then ended. These financial statements are the responsibility of the Foundation’s
Due from Affiliates, principally share of affiliate
contributions, less allowance for uncollectible amounts
of $200,000 in 2006 and 2005
management. Our responsibility is to express an opinion on these financial statements based on our
audit. The prior year summarized comparative information has been derived from the Foundation’s 2005
financial statements and, in our report dated September 12, 2005, we expressed an unqualified opinion
on these financial statements.
We conducted our audit in accordance with auditing standards generally accepted in the United States.
of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the
LIABILITIES AND NET ASSETS
Foundation’s internal control over financial reporting. Accordingly, we express no such opinion. An audit
Accounts payable and accrued expenses
also includes examining, on a test basis, evidence supporting the amounts and disclosures in the finan-
Payable to beneficiaries (Note 12)
369,450
382,790
Funds held in trust (Note 3)
448,035
409,377
Deferred income
4,277,112
4,952,409
Total liabilities
8,256,954
8,743,028
5,601,874
5,842,613
Temporarily restricted (Note 10)
11,940,261
11,023,883
Permanently restricted (Note 11)
174,237
174,237
Total net assets
17,716,372
17,040,733
Total liabilities and net assets
$25,973,326
$ 25,783,761
cial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audit provides a
reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material respects, the
Commitments (Notes 7 and 9)
financial position of the National Kidney Foundation, Inc. as of June 30, 2006, and the changes in its
net assets and its cash flows for the year then ended in conformity with accounting principles generally
NET ASSETS:
accepted in the United States.
Unrestricted
September 12, 2006
44
45
See accompanying notes.
National Kidney Foundation, Inc.
National Kidney Foundation, Inc.
Statement of Activities
Statement of Cash Flows
Year ended June 30, 2006 with summarized financial information for the year ended June 30, 2005
Unrestricted
Temporarily
Restricted
Permanently
Restricted
2006 Total
Year ended June 30
2006
2005 Total
$ 675,639
$ 3,069,129
Depreciation and amortization
158,808
148,077
Deferred rent
136,304
90,623
SUPPORT, REVENUE AND RECLASSIFICATIONS
Change in net assets
Support from the public:
Adjustments to reconcile change in net assets
to net cash provided by operating activities:
Received directly—contributions
Received indirectly—share of
Affiliate contributions
Total support from the public
Revenue:
Program service support and fees
Royalties
Dues—professional members
Investment income, including net
realized and unrealized gain on
appreciation of securities of
$604,807 in 2006 and
$422,140 in 2005
Other, net
Gain from settlement of
litigation (Note 8)
Total revenue and support
Net assets released from
restrictions (Note 10)
Total support, revenue
and reclassifications
$ 1,111,169
$ 570,762
$–
$ 1,681,931
$1,333,274
6,774,637
–
–
6,774,637
7,539,692
7,885,806
570,762
–
8,456,568
8,872,966
20,410,066
–
–
20,410,066
19,676,768
1,469,665
–
–
1,469,665
1,384,298
769,213
–
–
769,213
733,819
Write-off of inventory
Net realized and unrealized gains on investments
Due from Affiliates
Other receivables
295,574
1,035,287
–
1,330,861
1,053,779
16,183
–
–
16,183
237,704
–
–
–
–
2,200,000
30,846,507
1,606,049
–
32,452,556
34,159,334
(689,671)
–
–
–
31,536,178
916,378
–
32,452,556
34,159,334
–
3,006,090
3,030,340
Public health education
4,120,461
–
–
4,120,461
3,900,490
Professional education
10,281,072
–
–
10,281,072
9,761,647
5,338,221
–
–
5,338,221
5,461,476
4,516,656
–
–
4,516,656
4,349,260
27,262,500
–
–
27,262,500
26,503,213
Fundraising
1,385,691
–
–
1,385,691
1,371,271
Management and general
3,128,726
–
–
3,128,726
3,215,721
4,514,417
–
–
4,514,417
4,586,992
31,776,917
–
–
31,776,917
31,090,205
Change in net assets
Net assets at end of year
(4,324)
Accounts payable and accrued expenses
27,601
599,989
Payable to beneficiaries
(13,340)
114,082
Funds held in trust
38,658
27,821
(675,297)
(496,839)
1,419,185
2,774,010
(178,468)
(170,649)
Proceeds from sale of investments
2,032,143
7,587,702
Increase (decrease) in liabilities:
Net cash provided by operating activities
Supporting services:
Net assets at beginning of year
7,515
Purchases of fixed assets
–
Total expenses
(28,043)
CASH FLOWS FROM INVESTING ACTIVITIES
3,006,090
Total supporting services
135,625
(1,627,443)
1,040,651
Deferred income
Research
Assistance to Affiliates
(340,248)
1,552,558
10,283
Prepaid expenses
Program services:
Total program services
126,802
(422,140)
367,770
Inventories
Other assets
689,671
77,741
(604,807)
(Increase) decrease in assets:
EXPENSES
Patient services
2005
CASH FLOWS FROM OPERATING ACTIVITIES
(240,739)
916,378
–
675,639
3,069,129
5,842,613
11,023,883
174,237
17,040,733
13,971,604
$ 5,601,874
$ 11,940,261
$ 174,237
$ 17,716,372
$ 17,040,733
Purchases of investments
(5,826,429)
(7,506,956)
Net cash used in investing activities
(3,972,754)
(89,903)
Net (decrease) increase in cash and cash equivalents
(2,553,569)
2,684,107
Cash and cash equivalents at beginning of year
7,557,759
4,873,652
$ 5,004,190
$ 7,557,759
$ 250
$ 250
Cash and cash equivalents at end of year
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Unrelated business income taxes paid
See accompanying notes.
See accompanying notes.
46
47
National Kidney Foundation, Inc.
National Kidney Foundation, Inc.
Statement of Functional Expenses
Notes to Financial Statements
June 30, 2006
Year ended June 30, 2006 with summarized financial information for the year ended June 30, 2005
PROGRAM SERVICES
Research
Public
Health
Education
Professional
Education
TOTAL PROGRAM AND
SUPPORTING SERVICES
SUPPORTING SERVICES
Patient
Services
Assistance
to Affiliates
Total
FundRaising
Management
and
General
1. ORGANIZATION AND SUMMARY OF
SIGNIFICANT ACCOUNTING POLICIES
Total
2006
2005
$274,893
$779,568
$980,783
$1,033,281
$1,706,351
$4,774,876
$665,966
$1,351,586
$2,017,552
$6,792,428
$6,555,678
Employee benefits
49,640
148,919
173,739
186,149
410,198
968,645
124,099
270,615
394,714
1,363,359
1,286,427
Payroll taxes
18,912
56,735
66,191
70,919
118,198
330,955
47,279
94,559
141,838
472,793
514,247
2,446,783
–
–
–
–
2,446,783
–
–
–
2,446,783
2,474,529
19,973
67,474
512,296
81,579
213,031
894,353
48,267
257,939
306,206
1,200,559
1,717,042
29,960
131,950
138,802
143,785
122,226
566,723
42,065
99,277
141,342
708,065
457,111
Salaries
Awards and
grants (Note 9)
Professional fees
and contract
services
Office supplies and
expenses
8,087
18,961
21,789
23,148
36,630
108,615
16,432
30,023
46,455
155,070
157,210
Postage and
shipping
10,823
110,556
44,364
118,764
59,553
344,060
24,844
48,057
72,901
416,961
381,827
Building
occupancy
45,063
135,190
157,722
168,987
281,646
788,608
112,657
225,317
337,974
1,126,582
983,151
Telephone
Insurance
2,903
6,968
7,984
8,492
113,465
139,812
6,014
11,096
17,110
156,922
136,941
Printing and
publications
Meetings
and travel—
volunteers
2,990
145,909
578,478
133,373
2,990
863,740
3,204
12,230
15,434
879,174
1,041,554
–
–
–
–
225,183
225,183
–
212,614
212,614
437,797
499,571
Meetings and
travel—staff
20,992
121,722
123,006
129,433
190,125
585,278
41,109
95,752
136,861
722,139
704,938
Meetings and
travel—medical
10,485
12,587
83,048
129,244
–
235,364
–
750
750
236,114
82,457
Transplant games
–
773,762
–
773,762
–
1,547,524
–
–
–
1,547,524
2,252,863
Special projects
programs
–
1,571,393
7,218,251
2,352,400
479,847
11,621,891
73,011
366,359
439,370
12,061,261
10,909,433
Special projects
marketing
–
148,133
–
–
486,111
634,244
148,133
–
148,133
782,377
796,488
Subscriptions and
publications
–
21,697
–
11,499
–
33,196
10,198
–
10,198
43,394
39,385
Direct assistance to
patients
–
–
–
79,005
–
79,005
–
–
–
79,005
–
Membership dues
and support
15,033
15,033
15,033
15,033
–
60,132
–
–
–
60,132
62,245
Miscellaneous
expenses
34,069
43,853
109,720
61,360
48,885
297,887
15,410
36,131
51,541
349,428
436,782
2,990,606
4,310,410
10,231,206
5,520,213
4,494,439
27,546,874
1,378,688
3,112,305
4,490,993
32,037,867
31,489,879
15,484
19,930
49,866
27,887
22,217
135,384
7,003
16,421
23,424
158,808
148,077
3,006,090
4,330,340
10,281,072
5,548,100
4,516,656
27,682,258
1,385,691
3,128,726
4,514,417
32,196,675
31,637,956
–
(209,879)
–
(209,879)
–
(419,758)
–
–
–
(419,758)
(547,751)
$3,006,090
$4,120,461
$10,281,072
$5,338,221
$4,516,656
$ 27,262,500
$1,385,691
$3,128,726
$4,514,417
$31,776,917
$31,090,205
Current year’s
percentages
9.46%
12.97%
32.35%
16.80%
14.21%
85.79%
4.36%
9.85%
14.21%
100.00%
–
Last year’s
percentages
9.75%
12.55%
31.40%
17.56%
13.99%
85.25%
4.41%
10.34%
14.75%
–
100.00%
Depreciation and
amortization
Less cost of sales
Total expenses
reported by function
in the statement of
activities
See accompanying notes.
The National Kidney Foundation, Inc. (the “Foundation”),
headquartered in New York City, has chartered a network
of Affiliates and Divisions across the country to implement
its mission to prevent kidney and urinary tract diseases,
improve the health and well-being of individuals and families affected by these diseases and increase the availability
of all organs for transplantation.
Founded in 1950 to address the critical impact of these
diseases, the Foundation conducts nationwide educational
campaigns about the role of the kidney in maintaining
overall health, the importance of early detection and organ
donation and transplantation. The Foundation maintains a
Washington office to represent the needs of its constituents
by advocating for research and coverage of medications
needed by those with kidney failure, and also supports an
extensive scientifically meritorious research program. The
Foundation’s office in Kansas City provides services and
assistance to all Foundation Affiliates regarding organizational and fund-raising matters.
Under the provisions of a charter with the Foundation, each
Affiliate must meet certain requirements regarding organizational structure, program services and fund-raising.
COMPONENTS OF PROGRAM SERVICES
Research
The Foundation sponsors research that seeks answers to key
questions relating to kidney disease. Grants are provided
for studies aimed at finding treatments or to prevent kidney
disease as well as to improve the quality of life and long term
outlook for people with chronic kidney disease.
Public Health Education
The Foundation’s public health education efforts strive to
teach the public about kidney related issues such as causes
of kidney disease and the importance of early detection.
These efforts are made through the disbursement of educational brochures to the public, on-line health guides on the
Foundation’s Web site and through media outreach.
Professional Education
The Foundation provides consultation, guidance, training and
leadership to its Affiliates and other organizations. Specific
guidance is provided with informational booklets that cover
issues such as patient transportation programs, drug and
blood banks, and screening and detection programs.
Fund Accounting and Net Asset Classifications
To ensure observance of limitations and restrictions placed
on the use of resources available to the Foundation, the
Foundation’s accounts are maintained in accordance with
the principles of fund accounting. Separate accounts are
maintained for each fund; however, in the accompanying
financial statements, funds that have similar characteristics
have been combined into three net asset classes: unrestricted, temporarily restricted and permanently restricted.
Unrestricted Net Assets: Unrestricted net assets include
expendable resources over which the Foundation’s Board of
Directors has discretionary control and are used to carry out
the Foundation’s operations in accordance with its bylaws.
Included in unrestricted net assets are funds used to account for
fixed asset acquisitions, improvements and related activities.
Temporarily Restricted Net Assets: Temporarily restricted net
assets include resources expendable only for those purposes
specified by the donor or grantor. The restrictions are satisfied
either by the passage of time or by actions of the Foundation.
Permanently Restricted Net Assets: Permanently restricted net
assets include resources subject to donor-imposed stipulations
that they be maintained permanently by the Foundation.
Support and Revenue
Grants and contributions are recorded as revenue when
received or pledged unconditionally, at fair value. Contributions received with donor stipulations that limit the use
of the donated assets are reported as temporarily restricted
support. When a donor restriction expires, that is, when a
time restriction ends or purpose restriction is fulfilled, temporarily restricted net assets are reclassified to unrestricted net
assets and reported in the statement of activities as net assets
released from restrictions.
Due from Affiliates and Share of Affiliate Contributions
Patient Services
The Foundation and its Affiliates have agreements under
which a portion of contributions received by Affiliates is
shared with the Foundation. Amounts received but not remitted by Affiliates are recorded by the Foundation as due from
Affiliates. The Affiliates’ share of contributions solicited by
Affiliates and received directly by the Foundation is credited
to Affiliate receivables.
The patient services programs include initiatives to improve
patients’ health and quality of life. Programs include the
development of evidence-based practice guidelines for kidney
disease treatment, free screening for individuals at risk through
the Kidney Early Evaluation Program and patient empowerment programs that encourage patients to take charge of their
own health care.
From time to time, the Foundation makes cash advances or
short-term loans to various Affiliates for the purpose of funding
operations. The loans are interest bearing (at approximately
5% per annum) and repayable based on mutually agreeable
terms. These advances and short-term loans are included in
due from Affiliates in the accompanying balance sheet.
The Foundation’s program provides professionals with tools
needed to provide optimum patient care. Products provided
include toolkits, best practices, medical journals, and professional education conferences.
48
49
Program Assistance to Affiliates
Notes to Financial Statements (continuation)
Notes to Financial Statements (continuation)
1. ORGANIZATION AND SUMMARY OF SIGNIFICANT
ACCOUNTING POLICIES (continued)
Expense Allocations
The majority of expenses can generally be directly identified
with program or supporting services to which they relate and
are allocated accordingly. Other expenses have been allocated among program and supporting service classifications
primarily on the basis of the employees’ time allocations or
other methods determined by management.
Deferred Income
Deferred income consists primarily of amounts received
in advance for contracted programs, membership dues
and journal subscriptions that apply to future periods.
Membership dues and subscription revenue are recognized
as revenue over the respective membership and subscription periods. Revenues and expenses related to contracted
programs are recognized upon progression of the program
in accordance with the applicable agreement.
Donated Services
The Foundation’s volunteers, comprised of physicians, allied
health professionals, business and community leaders, kidney patients and their families, and others committed to the
Foundation’s mission, have made significant contributions
of their time to the Foundation’s programs and supporting
services. The value of such volunteers’ services has not been
reflected in the accompanying financial statements as it does
not meet the criteria for revenue recognition established
by Statement of Financial Accounting Standards No. 116,
Contributions Received and Contributions Made.
Cash and Cash Equivalents
The Foundation considers highly liquid financial instruments, excluding cash held in trust or held as part of the
investment portfolio, with maturities of three months or less
when purchased to be cash equivalents.
Inventories
Inventories, which consist of educational publications in
print and on CD-ROM, are stated at the lower of cost or
market determined by the first-in, first out method.
Investments and Investment Income
The Foundation carries investments in marketable equity
securities (including equity funds) with readily determinable
fair values and all investments in debt securities at their fair
values in the accompanying balance sheet. Fair values are
based on quoted market prices. Income earned from investments, including realized and unrealized gains and losses,
is recorded in the net asset class owning the assets with
the exception of permanently restricted net assets. Income
earned from permanently restricted investments, including
realized and unrealized gains and losses, is recorded as temporarily restricted for purposes specified by the donor.
Fixed Assets
Fixed assets are stated on the basis of cost or, as to donated
assets, fair value on the date donated. Depreciation is com-
4. CONTRIBUTIONS RECEIVABLE
puted by the straight-line method over the estimated useful
lives of the assets. Leasehold improvements are amortized
over the shorter of the remaining period of the lease or their
estimated useful lives.
Included in the above are assets held under split-interest agreements in the amount of approximately $922,000 and $817,000
at June 30, 2006 and 2005, respectively (see Note 12).
Summarized Financial Information
At June 30, 2006 and 2005, investments include amounts
held in trust of approximately $448,000 and $409,000,
respectively.
The accompanying financial statements include certain
prior year summarized comparative information in total but
not by net asset class. Such information does not include
sufficient detail to constitute a presentation in conformity
with accounting principles generally accepted in the United
States. Accordingly, such information should be read in
conjunction with the Foundation’s financial statements for
the year ended June 30, 2005 from which the summarized
information was derived.
At June 30, 2006 and 2005, $11,350,362 and $10,690,027,
respectively, of the investments relate to temporarily
restricted research endowment funds. Included in other
receivables are contributions receivable which represent
unconditional promises to give. At June 30, 2006 and
2005, these contributions receivable, with the noncurrent
portion discounted (at a rate of 6%) to present value, are
due to be collected as follows:
Use of Estimates
The preparation of financial statements in conformity with
accounting principles generally accepted in the United
States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities
and disclosure of contingent assets and liabilities at the date
of the financial statements and the reported amounts of
revenues and expenses during the reporting period. Actual
results could differ from those estimates.
Within one year
One to five years
Discount to
present value
Reclassification
(9,810)
(16,047)
$ 80,190
$ 103,953
Furniture and equipment, leasehold improvements, capitalized software and accumulated depreciation and amortization as of June 30, 2006 and 2005 are as follows:
2. TAX-EXEMPT STATUS
The Foundation is a not-for-profit voluntary health agency as
described in Section 501(c)(3) of the Internal Revenue Code
(the “Code”). The Foundation is exempt from Federal income
taxes under Section 501(a) of the Code and has been classified as a publicly supported charitable organization under
Section 509(a)(1) of the Code. The Foundation also is exempt
from New York State and City income taxes. Contributions
to the Foundation are deductible for income tax purposes to
the maximum extent allowed under the Code.
Furniture and equipment
Leasehold improvements
Capitalized software
$ 2,393,069
$ 1,911,026
4,345,031
4,226,598
5,637,006
5,139,542
901,369
806,122
3,226,185
20,279
$ 16,502,660
$ 12,103,567
779,061
620,253
$ 570,072
$ 550,412
The Foundation has a contributory retirement/savings plan.
The plan covers substantially all full-time employees who
meet certain age and service requirements. Under the terms
of the plan, contributions are made under Section 403(b) of
the Code and are invested, at the discretion of the plan participant, in one or more of the investment vehicles available
under the plan. Pension expense for the years ended June 30,
2006 and 2005 amounted to approximately $700,000 and
$540,000, respectively.
Fair Value
2005
2005
$ 929,629
175,940
65,096
1,170,665
6. RETIREMENT/SAVINGS PLAN
The fair value of investments and investments held under
split-interest agreements at June 30, 2006 and 2005 consisted of the following:
2006
2006
$ 1,060,906
210,662
77,565
1,349,133
Less accumulated depreciation and amortization
3. INVESTMENTS
Small cap stock fund
Cash and U.S. Government securities
2005
$ 30,000
90,000
5. FIXED ASSETS
Certain amounts in the 2005 financial statements have been
reclassified to conform to the 2006 presentation.
International
equity fund
Fixed income
securities fund
iShares index funds
2006
$ 30,000
60,000
50
51
During fiscal 2006, the Foundation adopted a Section 457(f)
Senior Staff Flexible Benefit Plan (the “Plan”), that provides
highly compensated employees with a benefit allowance
contributed by the Foundation, which can be used for
various benefit options, including a capital accumulation
account. Benefit expense related to the Plan totaled approximately $63,000. The fully funded liability related to the plan
amounted to approximately $45,000 at June 30, 2006 and is
included in accounts payable and accrued expenses in the
accompanying balance sheet.
During fiscal 2006, the Foundation also adopted a Section
457(f) Supplemental Executive Retirement Plan (SERP) for
one key employee. Benefit expense related to the SERP
totaled approximately $90,000. The fully funded liability
related to the plan amounted to approximately $90,000 at
June 30, 2006 and is included in accounts payable and
accrued expenses in the accompanying balance sheet.
7. COMMITMENTS
The Foundation occupies premises under noncancelable
operating leases in effect through 2019. Under the terms of
these operating leases, rental payments increase annually.
However, for financial statement purposes, rent expense is
recorded on the straight-line basis over the term of the lease.
The difference between rental payments made under the
lease and rent expense calculated on the straight-line basis
is recorded as deferred rent. At June 30, 2006 and 2005,
deferred rent of approximately $227,000 and $91,000 is
reflected in accounts payable and accrued expenses in the
accompanying balance sheet.
Rent expense approximated $1,127,000 and $953,000 for
the years ended June 30, 2006 and 2005, respectively.
Approximate future minimum lease payments are as follows:
2007
2008
2009
2010
2011
Thereafter
$ 849,000
838,000
857,000
877,000
897,000
9,261,000
$ 13,579,000
The Foundation has a line of credit not to exceed $1,000,000
at June 30, 2006. At June 30, 2006, there was no balance
outstanding under this credit line.
8. GAIN FROM SETTLEMENT OF LITIGATION
The gain on settlement of litigation recognized during the
year ended June 30, 2005 relates to a settlement reached
with a former Affiliate.
9. AWARDS AND GRANTS
As of June 30, 2006 and 2005, the Foundation has entered
into conditional multi-year research grant commitments. The
Foundation recognizes as expense the portion of the research
grant award that is unconditional in the year it becomes
unconditional. The Foundation has expensed research grants
of approximately $2,447,000 and $2,475,000 for the years
ended June 30, 2006 and 2005, respectively.
The outstanding commitments for research projects, which
are conditional at June 30, 2006, are scheduled for funding approximately as follows: fiscal 2007—$1,208,000 and
fiscal 2008—$150,000. These projects will be funded by
unrestricted and certain temporarily restricted net assets and
support and revenue to be generated by the Foundation.
Notes to Financial Statements (continuation)
National Kidney Foundation and Its Affiliates
10. TEMPORARILY RESTRICTED NET ASSETS
12. SPLIT-INTEREST AGREEMENTS
Combined Balance Sheet (unaudited)
Temporarily restricted net assets are restricted for the following purposes at June 30, 2006 and 2005:
The Foundation receives contributions under charitable gift
annuities. The Foundation has segregated these assets as
separate and distinct funds, independent from other funds
and not to be applied to payment of the debts and obligations of the Foundation or any other purpose other than
annuity benefits specified in the agreements. In addition,
this portfolio of assets meets all requirements concerning
permissible investments and mandated reserves as required
by law. The Foundation agrees to pay a stated return annually to the beneficiaries as long as they live, at which time
the remaining assets are available for unrestricted use of
the Foundation.
Research endowment
funds
Transplantation
guidelines
Transplant gamestravel support
Enuresis research
Other programs
2006
2005
$ 11,430,552
$ 10,793,980
423,540
158,275
9,593
35,413
38,356
38,220
$ 11,940,261
20,005
16,210
$ 11,023,883
Temporarily restricted net assets were released from restrictions in fiscal 2006 and 2005 as follows:
Research endowment funds
Other research
Other programs
2006
$446,146
152,483
91,042
$689,671
2005
$497,704
203,367
13,290
$714,361
11. PERMANENTLY RESTRICTED NET ASSETS
Permanently restricted net assets consist of investments that
are to be held in perpetuity with income therefrom available
to support clinical research in enuresis.
as of June 30, 2006
ASSETS
Cash and Cash Equivalents
Investments
Accounts Receivable
Inventories of Educational & Campaign Material
At June 30, 2006 and 2005, the total assets held under
split-interest agreements were approximately $922,000 and
$817,000, respectively, at fair value. The actuarial present value of the Foundation’s payable to beneficiaries was
approximately $369,000 and $383,000 at June 30, 2006
and 2005, respectively, and was calculated using interest
rates ranging from 5% to 6%.
Certain Affiliates have a beneficial interest in the expected
cash value of the gift annuities, which was approximately
$162,000 and $159,000 as of June 30, 2006 and 2005,
respectively, and is included in accounts payable and
accrued expenses in the accompanying balance sheet.
38,673,865
6,785,932
609,515
Prepaid Expenses
1,007,570
Property, Plant & Equipment, at cost
9,510,576
Less Accumulated Depreciation
(4,738,021)
Property, Plant & Equipment, net
4,772,555
Other Assets
1,199,823
Total Assets
$75,233,650
Liabilities
1. Accounting Standards
3. Composition of Financial Statements
The Foundation follows the standards of accounting and
reporting for voluntary health and welfare agencies developed by the National Health Council and National Social
Welfare Assembly.
The accompanying combined financial statements have
been prepared by the National Office from the individual
financial reports of each Affiliate and are not covered by the
report of Ernst&Young LLP. Each of the individual Affiliate
financial statements has been audited by other auditors as
a separate entity, and those reports are available from the
Affiliate upon request.
Loans Payable
$698,208
Accounts Payable & Accrued Expenses
5,878,862
Deferred Income
5,145,954
Other Liabilities
839,890
Total Liabilities
Combined Financial Statements (unaudited)
Expenses have been allocated to various classifications by
using time records and management’s estimation.
$22,184,390
LIABILITIES & NET ASSETS
National Kidney Foundation, Inc.
2. Functional Expenses
2006
12,562,914
Net Assets
Unrestricted
39,359,456
Temporarily Restricted
20,682,890
Permanently Restricted
Total Net Assets
Total Liabilities and Net Assets
Note: Figures from the NKF of Arkansas, Oklahoma and Texas Coastal Bend were not
received when this Annual Report went to press.
52
53
2,628,390
62,670,736
$75,233,650
National Kidney Foundation and Its Affiliates
National Kidney Foundation and Its Affiliates
Combined Statement of Activities (unaudited)
Combined Statement of Cash Flow (unaudited)
For the Year Ended June 30, 2006
For the Year Ended June 30, 2006
UNRESTRICTED
TEMPORARILY
RESTRICTED
PERMANENTLY
RESTRICTED
TOTAL 2006
2006
CASH FLOWS FROM OPERATING ACTIVITIES:
SUPPORT, REVENUE AND RECLASSIFICATIONS
Change in Net Assets
Support from the Public:
Adjustments to Reconcile Change in Net Assets to Net Cash
Received Directly:
Provided by Operating Activities:
$23,633,886
$4,500,796
$71,095
$28,205,777
Special Events Revenue
21,572,250
499,539
0
22,071,789
Less: Direct Benefit Costs
(10,054,612)
(150,891)
0
(10,205,503)
Net Support from Special Events
11,517,638
348,648
0
11,866,286
Contributions
Depreciation and Amortization
Unrealized Gain/Loss on Investments
Loss on Disposal of Fixed Assets
Donated Stocks
Received Indirectly:
United & Federated Funds
900,523
234,059
0
1,134,582
Combined Federal Campaign
435,928
47,628
0
483,556
36,487,975
5,131,131
71,095
41,690,201
3,688,435
294,312
0
3,982,747
Total Support from the Public
Government Grants
Donated Fixed Assets
Membership Dues
Sale of Literature & Drugs (net of expense)
Investment Income
Accounts Receivable
1,114,314
0
22,764,733
839,981
0
0
839,981
Inventories of Educational & Campaign Material
Prepaid Expenses
483,747
Other Assets
518,164
430,409
9,607
0
440,016
1,843,192
1,164,342
0
3,007,534
0
0
10,714,404
Accounts Payable & Accrued Expenses
0
(14,030,350)
Deferred Income
Net Sales of Donated Vehicles
(3,315,946)
0
0
(3,315,946)
Miscellaneous Revenue
2,236,129
0
0
2,236,129
Total Other Revenue
23,684,184
2,288,263
0
25,972,447
Total Support and Other Revenue
63,860,594
7,713,706
71,095
71,645,395
7,005,000
(7,005,000)
0
0
$70,865,594
$708,706
$71,095
$71,645,395
Other Liabilities
Net Cash Provided by Operating Activities
Purchase of Fixed Assets
Proceeds from the Disposition of Fixed Assets
Proceeds from the Sale of Investments
Program Services:
$5,089,177
$5,089,177
Public Health Education
11,774,669
11,774,669
Professional Education
13,533,889
13,533,889
Patient Services
16,832,216
16,832,216
9,668,306
9,668,306
56,898,257
56,898,257
Management and General
Total Expenses
Change in Net Assets
Net Assets at the Beginning of the Year, as Restated
Net Assets at the End of the Year
$69,262,378
$69,262,378
1,603,216
708,706
71,095
2,383,017
37,756,240
19,974,184
2,557,295
60,287,719
$39,359,456
$20,682,890
$2,628,390
$62,670,736
9,615,303
(3,191,355)
Contributions to Endowment
71,095
Proceeds from Loans Payable
144,328
Repayment of Loans Payable
(50,060)
Net Cash Used in Financing Activities
Cash and cash equivalents at end of year
6,105,160
12,364,121
(687,588)
2,182,364
Net cash Used in Investing Activities
Cash and cash equivalents at beginning of year, as restated
6,105,160
(89,889)
2,470,678
(14,301,433)
6,258,961
12,364,121
(538,526)
CASH FLOWS FROM FINANCING ACTIVITIES:
Supporting Services:
Total Supporting Services
(1,418,514)
Purchases of Investments
Net increase/(decrease) in cash and cash equivalents
6,258,961
61,157
CASH FLOWS FROM INVESTING ACTIVITIES:
EXPENSES
Fund-raising
2,127,000
21,650,419
0
Total Program Services
136,304
CHANGES IN OPERATING ASSETS AND LIABILITIES (AS RESTATED):
10,714,404
Community Services
(54,700)
(414,885)
10,714,404
(14,030,350)
Research
(39,555)
(10,709,808)
Sales of Donated Vehicles
Total Support, Revenue and Reclassifications
(1,280,234)
Cost of Sales of Contributed Vehicles
Less: Cost of Sales & Selling Expenses
Net Assets Released From Restrictions
592,996
Contribution of Vehicles
Deferred Rent
Other Revenue:
Program Service Fees
$2,383,017
165,363
(555,314)
22,739,703
$22,184,390
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Interest paid
Income taxes paid
54
55
Noncash investing and financing activities-in-kind donations
20,378
250
722,714
National Kidney Foundation and Its Affiliates
Combined Statement of Functional Expenses (unaudited)
For the Year Ended June 30, 2006
PROGRAM SERVICES
Public
Health
Education
Research
Salaries
Employee Benefits
Professional
Education
SUPPORTING SERVICES
Patient
Services
Community
Services
Fund-raising
Mgt &
General
Total
Expenses
$739,383
$4,352,738
$2,202,477
$4,637,361
$4,229,290
$2,498,876
$2,635,411
$21,295,536
100,624
616,021
323,673
681,171
750,296
377,785
442,675
3,292,245
57,920
350,327
166,001
373,050
319,878
205,585
209,666
1,682,427
Awards and Grants
3,608,969
378,472
95,828
198,184
41,658
12,499
3,201
4,338,811
Professional Fees
& Contract Services
93,776
482,241
757,908
485,452
411,392
289,626
664,883
3,185,278
-
-
-
4,285,763
-
-
-
4,285,763
58,317
327,797
298,839
468,832
276,379
202,242
212,088
1,844,494
Payroll Taxes
Assistance to Patients
Office Supplies and
Expenses
Telephone
28,685
120,450
60,470
120,227
105,814
76,259
70,010
581,915
Postage and Shipping
21,195
202,952
88,174
211,898
127,107
189,774
90,320
931,420
133,303
596,507
478,580
665,748
604,806
348,260
412,833
3,240,037
8,672
39,643
21,107
48,091
144,786
32,029
47,409
341,737
Printing, Publication
and Audio-Visual
25,567
396,916
671,594
266,385
145,154
343,444
82,319
1,931,379
Meetings, Symposia
and Related Travel
57,274
346,284
563,430
574,544
687,503
221,748
436,752
2,887,535
Membership dues
and Subscriptions
16,184
50,245
20,052
40,279
9,120
19,458
16,758
172,096
Miscellaneous Expenses
49,524
307,093
218,253
415,295
139,887
69,728
240,804
1,440,584
-
-
10,205,503
-
10,205,503
Building Occupancy
Insurance
Unallocated Direct
Benefit Costs
Depreciation
and amortization
42,726
163,857
101,471
197,057
115,217
64,348
90,184
774,860
Special Projects
13,826
3,123,969
7,428,209
3,370,480
1,493,761
569,883
426,599
16,426,727
Promotion Costs
33,232
129,036
37,823
86,828
66,258
45,383
23,248
421,808
Donated Vehicles
Cost of Sales
-
-
-
-
-
-
10,714,404
10,714,404
Donated Vehicles
Service Providers
-
-
-
-
-
692,034
3,315,946
4,007,980
Total expenses
$5,089,177
$11,984,548
$13,533,889
$17,126,645
$9,668,306
$16,464,464
$20,135,510
$94,002,539
$-
$-
$-
$10,205,503
$-
$10,205,503
Cost of Sales
-
209,879
-
294,429
-
-
Cost of Sales /
Selling Expenses
Donated Vehicles
-
-
-
-
-
-
14,030,350
14,030,350
$5,089,177
$11,774,669
$13,533,889
$16,832,216
$9,668,306
$6,258,961
$6,105,160
$69,262,378
7.3%
17.0%
19.5%
24.4%
14.0%
9.0%
8.8%
100.0%
Less: Expenses Netted
with Revenues on the
Statement of Activities:
Direct Expenses
of Special Events
Total Expenses
Reported by Function
Percentages
504,308
MORE THAN 20 MILLION AMERICANS—ONE IN NINE ADULTS—
HAVE CHRONIC KIDNEY DISEASE, AND MOST DON’T EVEN
KNOW IT. MORE THAN 20 MILLION OTHERS ARE AT INCREASED
RISK. THE NATIONAL KIDNEY FOUNDATION, A MAJOR
VOLUNTARY HEALTH ORGANIZATION, SEEKS TO PREVENT
KIDNEY AND URINARY TRACT DISEASES, IMPROVE THE HEALTH
AND WELL-BEING OF INDIVIDUALS AND FAMILIES AFFECTED
BY THESE DISEASES, AND INCREASE THE AVAILABILITY OF ALL
ORGANS FOR TRANSPLANTATION. THROUGH ITS AFFILIATES
AND DIVISIONS NATIONWIDE, THE FOUNDATION CONDUCTS
PROGRAMS IN RESEARCH, PROFESSIONAL EDUCATION,
PATIENT AND COMMUNITY SERVICES, PUBLIC EDUCATION
AND ORGAN DONATION.
MAKING HEADLINES
In 2006 the NKF Generated
265,529,182 Total Media Impressions